Position in AXSM
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$97,908
+$24,852 QoQ
Shares Held
400
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#417
of 494 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TRUST CO OF VERMONT holds $594,583 across 13 Biotechnology names. AXSM ranks #3 (16.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
360 | $178,822 | |
| 2 | OCUL |
Ocular Therapeutix, Inc
|
11,450 | $112,439 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
This page
|
400 | $97,908 | |
| 4 | ARGX |
Argenx SE
|
104 | $96,488 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
47 | $29,306 | |
| 6 | MRNA |
Moderna, Inc.
|
255 | $17,857 | |
| 7 | AUPH |
Aurinia Pharmaceuticals Inc.
|
1,000 | $16,970 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
200 | $15,654 |
All Filings in AXSM
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $97,908 | 400 | Shares | Sole | 2026-08-07 | |
| 2025-12-31 | $73,056 | 400 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $48,580 | 400 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $41,756 | 400 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $46,652 | 400 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $42,305 | 500 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $44,935 | 500 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $40,250 | 500 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $39,900 | 500 | Shares | Sole | 2024-05-03 | |
| No filing history on record for this holder in this stock. | ||||||